CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $256,000 | -35.5% | 103,800 | -5.7% | 0.22% | -40.8% |
| Q1 2017 | $397,000 | +2.1% | 110,050 | +0.1% | 0.37% | -11.7% |
| Q4 2016 | $389,000 | -14.1% | 109,950 | -2.0% | 0.42% | -3.7% |
| Q3 2016 | $453,000 | -7.6% | 112,200 | +0.5% | 0.44% | -15.7% |
| Q2 2016 | $490,000 | +84.2% | 111,600 | +58.5% | 0.52% | +76.1% |
| Q1 2016 | $266,000 | -65.0% | 70,400 | +45.3% | 0.29% | -63.7% |
| Q4 2015 | $760,000 | – | 48,450 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |